193 related articles for article (PubMed ID: 37711742)
1. Differential modulation of IL-4, IL-10, IL-17, and IFN-γ production mediated by IgG from Human T-lymphotropic virus-1 (HTLV-1) infected patients on healthy peripheral T (CD4+, CD8+, and γδ) and B cells.
Machado NR; Fagundes BO; Fernandes LA; de Oliveira ACP; Nukui Y; Casseb J; Cunha FRM; Nali LHDS; Sanabani SS; Victor JR
Front Med (Lausanne); 2023; 10():1239706. PubMed ID: 37711742
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
3. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
4. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
[TBL] [Abstract][Full Text] [Related]
5. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
6. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.
Best I; López G; Verdonck K; González E; Tipismana M; Gotuzzo E; Vanham G; Clark D
Immunology; 2009 Sep; 128(1 Suppl):e777-86. PubMed ID: 19740339
[TBL] [Abstract][Full Text] [Related]
8. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
[TBL] [Abstract][Full Text] [Related]
9. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
[TBL] [Abstract][Full Text] [Related]
10. The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.
Montanheiro PA; Penalva de Oliveira AC; Smid J; Fukumori LM; Olah I; da S Duarte AJ; Casseb J
Scand J Immunol; 2009 Oct; 70(4):403-7. PubMed ID: 19751276
[TBL] [Abstract][Full Text] [Related]
11. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.
de Sena Rodrigues Júnior R; Antonia Nunes Gomes J; Alberto da Silva Dias G; Fujihara S; Toshimitsu Yoshikawa G; Vilela Lopes Koyama R; Catarina Medeiros Sousa R; Antonio Simões Quaresma J; Thais Fuzii H
Immunobiology; 2023 Nov; 228(6):152740. PubMed ID: 37657359
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
Goncalves DU; Proietti FA; Barbosa-Stancioli EF; Martins ML; Ribas JG; Martins-Filho OA; Teixeira-Carvalho A; Peruhype-Magalhães V; Carneiro-Proietti AB
Inflamm Allergy Drug Targets; 2008 Jun; 7(2):98-107. PubMed ID: 18691139
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
[TBL] [Abstract][Full Text] [Related]
14. Decoding pathogenesis factors involved in the progression of ATLL or HAM/TSP after infection by HTLV-1 through a systems virology study.
Zarei Ghobadi M; Emamzadeh R; Teymoori-Rad M; Mozhgani SH
Virol J; 2021 Aug; 18(1):175. PubMed ID: 34446027
[TBL] [Abstract][Full Text] [Related]
15. Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
Rajaei T; Farajifard H; Rezaee SA; Azarpazhooh MR; Mahmoudi M; Valizadeh N; Rafatpanah H
Med Microbiol Immunol; 2019 Oct; 208(5):641-650. PubMed ID: 30341468
[TBL] [Abstract][Full Text] [Related]
16. Retrovirally induced CTL degranulation mediated by IL-15 expression and infection of mononuclear phagocytes in patients with HTLV-I-associated neurologic disease.
Enose-Akahata Y; Oh U; Grant C; Jacobson S
Blood; 2008 Sep; 112(6):2400-10. PubMed ID: 18509087
[TBL] [Abstract][Full Text] [Related]
17. Minocycline modulates antigen-specific CTL activity through inactivation of mononuclear phagocytes in patients with HTLV-I associated neurologic disease.
Enose-Akahata Y; Matsuura E; Tanaka Y; Oh U; Jacobson S
Retrovirology; 2012 Feb; 9():16. PubMed ID: 22335964
[TBL] [Abstract][Full Text] [Related]
18. Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.
Yamauchi J; Coler-Reilly A; Sato T; Araya N; Yagishita N; Ando H; Kunitomo Y; Takahashi K; Tanaka Y; Shibagaki Y; Nishioka K; Nakajima T; Hasegawa Y; Utsunomiya A; Kimura K; Yamano Y
J Infect Dis; 2015 Jan; 211(2):238-48. PubMed ID: 25104771
[TBL] [Abstract][Full Text] [Related]
19. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profile and proviral load among Japanese immigrants and non-Japanese infected with HTLV-1 in a non-endemic area of Brazil.
Domingos JA; Soares LS; Bandeira LM; Bonin CM; Vicente AC; Zanella L; Puga MA; Tozetti IA; Motta-Castro AR; da Cunha RV
PLoS One; 2017; 12(4):e0174869. PubMed ID: 28376092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]